Back to search
SMARCB1-Deficient Malignancies
Clinical trial pipeline · Data from ClinicalTrials.gov
See which SMARCB1-Deficient Malignancies trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which SMARCB1-Deficient Malignancies trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This phase I/II trial studies how well tiragolumab and atezolizumab works when given to children and adults with SMARCB1 or SMARCA4 deficient tumors that have e…
This research study involves a combination of three drugs given together as a possible treatment for malignant rhabdoid tumor, atypical teratoid rhabdoid tumor,…